BE Health is a “hospital VC” dedicated to advancing innovation in MedTech and HealthTech. Combining the strengths of BE Accelerator and BE Health Ventures, we bridge the gap between medical innovation and real-world application by supporting early-stage startups with clinical validation, market access, and cross-border expansion.
Founded in 2018, BE Health works closely with leading medical institutions—Taipei Medical University, Show Chwan Health Care System and many more international hospital systems—to provide startups with direct access to clinical expertise and real-world testing environments. Our network also includes academic partners, global investors, and industry experts committed to building a thriving ecosystem for healthcare innovation.
Moving forward, BE Health will continue to expand our international partnerships, deliver unique accelerator programs, host diverse industry events, and strengthen our role as “The Gateway to Asia for MedTech and HealthTech”.
The healthcare ecosystem is particularly complex. Due to the associated risks of failure, it has been an innovation averse industry. There are numerous factors that are endemic to the industry such as institutional policies, hierarchical systems, long sales cycles and high costs. Despite these challenges, we are bullish about the opportunities that innovation will provide to the healthcare ecosystem. The BE team works tirelessly to improve the success rate of both local and international startups looking to start in or scale up in various Asian territories.
Backed by a supportive government, increase in venture capital and startup friendly regulations, Taiwan punches well above its weight as a startup ecosystem.
Average for 3 hour flight to six major cities in east Asia.
Over 20 years of digitized, single payer medical dats from NHI.
Strength in creating proprietary technology, R&D and manufacturing.
Focus on having an innovation-driven economy.
Access to high quality talent, specifically in engineering.
Taiwan Entrepreneurship Visa process aids startup community.
IP laws are open, transparent and adhere to international standards.
Stable exchange rate& policies to attract foreign investment.
 |
 |
 |
|
|---|---|---|---|
| Who Can Apply? | International & local startup teams | Local startup teams | International & local startup teams |
| Location | Taiwan based, Hybrid Executed | Taiwan based, Hybrid Executed | Taiwan based, Hybrid Executed |
| Stage | Pre Seed – Series A | Seed – Series B | Pre Series A – Series B |
| Needs | Proof of Clinical Evidence | Proof of Business / Service | Market Expansion; Clinical Validation |
| Duration | 20–24 weeks | Corporate dependent: Corporate Partner Accelerating Project | Startups dependent |
| Admission | 1 batch per year Recruiting: Oct – Dec | Current batch: Rolling Recruitment | Continuous intake |
| Financing | No investment guaranteed (Min. 1 startup per batch will be recruited into PIM) | No investment guaranteed | Initial investment from 500k–2M USD |
| Mentoring | During the 20-week program | During the 24-week program | Continuous mentoring |
| Industries | Healthtech & Medtech | Ageing-tech, Homecare, Hospital at Home | HealthTech & MedTech |
| Office Space | Co-working @ Taiwan Tech Arena | Co-working @ Startup Terrace Kaohsiung | Co-working @ Taiwan Tech Arena |
| Conclusion | Demo Day | Demo Day | NA |
Founder & Managing Partner
Venture Partner
VP, Medical Affairs
Investment Manager
Senior Marketing Specialist
General Partner
Accelerator Co-Founder
Strategic Partnership & Global Marketing Director
Program Manager
Corporate Program Manager
General Partner ZHI KANG Venture Capital
Entrepreneur in Residence
Program Director
Project Lead, Japan Business Development
Accounting Manager
General Partner
VP, Investment
CPA (US) Investment Director
Program Manager
Special Assistant, Office of Managing Partner